Pipeline

Pipeline

We have a dedicated pharmaceutical drug research and development team, including formulation experts, analytical chemists, and clinical and regulatory specialists who are leaders in both science and development of pharmaceutical products.

We have a rich history of R&D achievements and a vast intellectual property portfolio, including our blockbuster drug, Lidoderm — a drug that has generated more than $1 billion in annual sales on the market.

We continue to focus on Central Nervous System (CNS) disorder, pain management and oncology and at times opportunities outside our core therapeutics area.